Deuterium‐ and Tritium‐Labelled Compounds: Applications in the Life Sciences |
| |
| Authors: | Dr. Jens Atzrodt Dr. Volker Derdau Prof. Dr. William J. Kerr Dr. Marc Reid |
| |
| Affiliation: | 1. Isotope Chemistry and Metabolite Synthesis, Integrated Drug Discovery, Medicinal Chemistry, Frankfurt, Germany;2. Department of Pure and Applied Chemistry, WestCHEM, University of Strathclyde, Glasgow, Scotland, UK |
| |
| Abstract: | Hydrogen isotopes are unique tools for identifying and understanding biological and chemical processes. Hydrogen isotope labelling allows for the traceless and direct incorporation of an additional mass or radioactive tag into an organic molecule with almost no changes in its chemical structure, physical properties, or biological activity. Using deuterium‐labelled isotopologues to study the unique mass‐spectrometric patterns generated from mixtures of biologically relevant molecules drastically simplifies analysis. Such methods are now providing unprecedented levels of insight in a wide and continuously growing range of applications in the life sciences and beyond. Tritium (3H), in particular, has seen an increase in utilization, especially in pharmaceutical drug discovery. The efforts and costs associated with the synthesis of labelled compounds are more than compensated for by the enhanced molecular sensitivity during analysis and the high reliability of the data obtained. In this Review, advances in the application of hydrogen isotopes in the life sciences are described. |
| |
| Keywords: | deuterium drug discovery isotopic labeling life sciences tritium |
|
|
